SS Innovations International (SSII) Cash from Investing Activities (2017 - 2026)
SS Innovations International's (SSII) quarterly Cash from Investing Activities came in at -$54189.0 in Q1 2026, up 93.79% year-on-year from -$27962.5 in Q1 2025, and up 96.84% quarter-over-quarter from -$1.7 million in Q4 2025.
SS Innovations International (SSII) Cash from Investing Activities (2017 - 2026) Analysis & Trends
SS Innovations International has disclosed Cash from Investing Activities across 10 years of filings, most recently posting -$54189.0 for Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$54189.0, up 93.79% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.8 million (down 101.88% YoY), and the FY2025 annual result was -$3.7 million, down 453.16% from the prior year.
- Cash from Investing Activities came in at -$54189.0 for Q1 2026 at SS Innovations International, up from -$1.7 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $1.7 million in Q3 2024 to a low of -$2.1 million in Q2 2024.
- The 5-year median for Cash from Investing Activities is -$127255.0 (2024), against an average of -$331267.5.
- Across the five-year window, Cash from Investing Activities tumbled 6329.8% in 2023 and jumped 872.1% in 2024, its largest moves.
- SS Innovations International's Cash from Investing Activities stood at -$137530.0 in 2022, then rose by 7.48% to -$127249.0 in 2023, then climbed by 1.66% to -$125142.0 in 2024, then plunged by 1270.07% to -$1.7 million in 2025, then jumped by 96.84% to -$54189.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$54189.0 (Q1 2026), -$1.7 million (Q4 2025), and -$755075.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn | -54,189.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54,189.00 |
| Mar 31, 2026 | -54,189.00 |
| Dec 31, 2025 | -1.71 Mn |
| Dec 31, 2025 | -1.71 Mn |
| Sep 30, 2025 | -755,075.00 |
| Sep 30, 2025 | -755,075.00 |
| Jun 30, 2025 | -316,648.00 |
| Jun 30, 2025 | -316,648.00 |
| Mar 31, 2025 | -872,804.00 |
| Mar 31, 2025 | -872,804.00 |
| Dec 31, 2024 | -125,142.00 |
| Dec 31, 2024 | -125,142.00 |
| Sep 30, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | -2.11 Mn |
| Jun 30, 2024 | -2.11 Mn |
| Mar 31, 2024 | -127,255.00 |
| Mar 31, 2024 | -127,255.00 |
| Dec 31, 2023 | -127,249.00 |
| Dec 31, 2023 | -127,249.00 |